Wound Care & Skin Substitutes

What they are

Skin substitutes — Cellular and Tissue-Based Products (CTPs) — are biologic materials derived from human, animal or synthetic sources. Many allograft products are derived from amniotic membrane or other human tissue. They're regulated as human tissue products, not as drugs or traditional devices.

They're designed to provide a scaffold for tissue regeneration, support cellular migration and wound healing, reduce inflammation, and accelerate closure of chronic wounds.

When they're indicated

Chronic wounds are a significant clinical and financial burden. The wound types that commonly qualify for advanced therapies are diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure injuries (Stage III/IV), and certain surgical or traumatic wounds. When standard of care fails to achieve adequate healing progress, providers may escalate to advanced modalities including CTPs.

What payers require

Medicare and most commercial payers require documentation that:

• The wound is chronic — typically 4+ weeks in duration
• Standard of care has been provided and documented
• The wound has failed to achieve adequate healing progress
• The wound meets size and clinical criteria under the applicable Local Coverage Determination (LCD)

Standard of care typically means debridement, offloading (for DFUs), compression (for VLUs), infection control and a moist wound environment. Failure to document standard of care is a common audit trigger.

How reimbursement works

It depends on site of service. In a physician office (PFS), the product is billed separately — often ASP-based or invoice-based depending on classification — and the application procedure is billed via CPT code. In hospital outpatient (OPPS), product and procedure reimbursement may be bundled or packaged depending on status indicator.

The key variables are product cost, wound size in square centimetres applied, number of applications, and payer-specific rules. Improper billing or overutilisation can trigger post-payment review.

LCDs are the rulebook

Local Coverage Determinations, issued by regional MACs, define covered wound types, required duration of standard of care, documentation elements, frequency limitations, maximum number of applications, and non-covered indications. LCD compliance is mandatory for Medicare reimbursement — and failure to align documentation with LCD language is one of the primary causes of denials and recoupments.

The scrutiny is real, and it is increasing

Skin substitute utilisation has drawn federal oversight because of rapid growth in expenditures, variability in product pricing, outlier billing patterns and insufficient documentation of medical necessity. The bodies involved are MACs, Unified Program Integrity Contractors (UPICs), the OIG and the DOJ. Post-payment audits can result in recoupment if documentation doesn't support medical necessity.

Common audit triggers: excessive application frequency, large cumulative graft sizes, lack of documented standard of care, template-based or cloned documentation, and inconsistent wound measurements. Higher-dollar cases attract disproportionately more scrutiny — in those, minor documentation deficiencies can produce substantial recoupments.

Revenue without compliance structure becomes financial liability. Wound Care 101 — Paradygm Health Group

Where practices are exposed

• Inadequate patient qualification screening
• Missing or inconsistent wound measurements
• Failure to document prior standard of care
• Overutilisation relative to LCD guidance
• Poor coordination between clinical and billing teams
• Lack of audit-ready record organisation

Most compliance failures here don't come from improper clinical intent. They come from inconsistent documentation language, incomplete eligibility verification, gaps between clinical and billing teams, no utilisation tracking, and reactive rather than proactive audit preparation.

What we build instead

A defensible program needs pre-treatment eligibility verification, LCD-driven documentation templates, utilisation monitoring, accurate wound measurement tracking, billing aligned to payer rules, and ongoing audit preparedness. Programs that succeed long-term treat documentation and compliance as infrastructure — not as an afterthought.

Built into the workflow from day one, those safeguards let a practice participate in advanced wound care with significantly greater confidence: fewer denials, fewer clawbacks, audits withstood, revenue that holds.

A successful program stands on two pillars — clinical appropriateness, and documentation and compliance integrity. Without both, the financial and regulatory risk can outweigh the opportunity.